{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:58:56Z","timestamp":1794203936925,"version":"4.8.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.critrevonc.2022.103745","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T12:21:41Z","timestamp":1655727701000},"page":"103745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions"],"prefix":"10.1016","volume":"176","author":[{"given":"Vivian P.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin D.","family":"Bingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Bingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.critrevonc.2022.103745_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jmoldx.2014.03.006","article-title":"Detection of gene rearrangements in targeted clinical next-generation sequencing","volume":"16","author":"Abel","year":"2014","journal-title":"J. Mol. Diagn."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103745_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.oraloncology.2013.05.013","article-title":"Salivary gland cancer stem cells","volume":"49","author":"Adams","year":"2013","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41389-020-0194-3","article-title":"ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma","volume":"9","author":"Andersson","year":"2020","journal-title":"Oncogenesis"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103745_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx017","article-title":"Targeting the oncogenic transcriptional regulator MYB in adenoid cystic carcinoma by inhibition of IGF1R\/AKT signaling","volume":"109","author":"Andersson","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2022.103745_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cancergen.2019.08.005","article-title":"Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing","volume":"239","author":"Au","year":"2019","journal-title":"Cancer Genet."},{"key":"10.1016\/j.critrevonc.2022.103745_bib6","article-title":"Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies","author":"Azorsa","year":"2020","journal-title":"Mod. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ng.3500","article-title":"MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism","volume":"48","author":"Bandopadhayay","year":"2016","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103745_bib8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/PAS.0000000000001447","article-title":"A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma","volume":"44","author":"Baranov","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103745_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4161\/cbt.12.7.17008","article-title":"Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma","volume":"12","author":"Bell","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103745_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/gcc.20306","article-title":"Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene","volume":"45","author":"Behboudi","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103745_bib11","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/modpathol.2011.86","article-title":"Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms","volume":"24","author":"Brill","year":"2011","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13059-015-0718-x","article-title":"Quantitative detection of rare interphase chromosome breaks and translocations by high-throughput imaging","volume":"16","author":"Burman","year":"2015","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103745_bib13","doi-asserted-by":"crossref","first-page":"a002626","DOI":"10.1101\/mcs.a002626","article-title":"Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making","volume":"4","author":"Chahal","year":"2018","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103745_bib14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4161\/cbt.7.11.6722","article-title":"c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster","volume":"7","author":"Chung","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"34","key":"10.1016\/j.critrevonc.2022.103745_bib15","doi-asserted-by":"crossref","first-page":"30254","DOI":"10.1074\/jbc.M504703200","article-title":"Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants","volume":"280","author":"Corradini","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103745_bib16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/labinvest.2014.59","article-title":"Analysis of MYB oncogene in transformed adenoid cystic carcinomas reveals distinct pathways of tumor progression","volume":"94","author":"Costa","year":"2014","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2014.29","article-title":"vaccination against colorectal cancer by targeting the MYB oncoprotein","volume":"4","author":"Cross","year":"2015","journal-title":"Clin. Transl. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103745_bib18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/odi.12984","article-title":"t(6;9)(MYB-NFIB) in head and neck adenoid cystic carcinoma: A systematic review with meta-analysis","volume":"25","author":"de Almeida-Pinto","year":"2019","journal-title":"Oral Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng.3502","article-title":"An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma","volume":"48","author":"Drier","year":"2016","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103745_bib20","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1073\/pnas.77.9.5120","article-title":"Genetic structure of avian myeloblastosis virus, released from transformed myeloblasts as a defective virus particle","volume":"77","author":"Duesberg","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/1078-0432.CCR-20-1192","article-title":"Proteogenomic analysis of salivary adenoid cystic carcinomas defines molecular subtypes and identifies therapeutic targets","volume":"27","author":"Ferrarotto","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/cancers12010045","article-title":"N-terminal truncated Myb with new transcriptional activity produced through use of an alternative MYB promoter in salivary gland adenoid cystic carcinoma","volume":"12","author":"Frerich","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103745_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/his.13281","article-title":"MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma","volume":"71","author":"Fujii","year":"2017","journal-title":"Histopathology"},{"issue":"24","key":"10.1016\/j.critrevonc.2022.103745_bib24","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.18632\/oncotarget.2985","article-title":"A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets","volume":"5","author":"Gao","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103745_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/DAD.0000000000001755","article-title":"MYB translocations in both myoepithelial and ductoglandular epithelial cells in adenoid cystic carcinoma: a histopathologic and genetic reappraisal in six primary cutaneous cases","volume":"43","author":"Goto","year":"2021","journal-title":"Am. J. Derm."},{"key":"10.1016\/j.critrevonc.2022.103745_bib26","first-page":"272","article-title":"Transmission of fowl leukosis through chick embryos and young chicks","volume":"2","author":"Hall","year":"1941","journal-title":"Am. J. Vet. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib27","first-page":"2915","article-title":"Analysis of clinicopathological characteristics, MYB rearrangement and prognostic factors in salivary adenoid cystic carcinoma","volume":"17","author":"Han","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2022.103745_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104690","article-title":"Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma","volume":"106","author":"Hanna","year":"2020","journal-title":"Oral Oncol."},{"key":"10.1016\/j.critrevonc.2022.103745_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105366","article-title":"A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma","volume":"119","author":"Hanna","year":"2021","journal-title":"Oral Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103745_bib30","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1172\/JCI128227","article-title":"Genetic hallmarks of recurrent\/metastatic adenoid cystic carcinoma","volume":"129","author":"Ho","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2022.103745_bib31","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3389\/fgene.2019.01313","article-title":"Location of balanced chromosome-translocation breakpoints by long-read sequencing on the Oxford nanopore platform","volume":"10","author":"Hu","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2022.103745_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.oraloncology.2019.09.005","article-title":"MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma","volume":"98","author":"Jiang","year":"2019","journal-title":"Oral Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103745_bib33","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1158\/1078-0432.CCR-17-3871","article-title":"Salivary gland cancer patient-derived xenografts enable characterization of cancer stem cells and new gene events associated with tumor progression","volume":"24","author":"Keysar","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103745_bib34","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/hed.25597","article-title":"The value of MYB as a prognostic marker for adenoid cystic carcinoma: meta-analysis","volume":"41","author":"Liu","year":"2019","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103745_bib35","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20180939","article-title":"Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma","volume":"215","author":"Mandelbaum","year":"2018","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.critrevonc.2022.103745_bib36","first-page":"2311","article-title":"The WNT\/MYB pathway suppresses KIT expression to control the timing of salivary proacinar differentiation and duct formation","volume":"143","author":"Matsumoto","year":"2016","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13000-019-0855-8","article-title":"MYB-NFIB gene fusions identified in archival adenoid cystic carcinoma tissue employing NanoString analysis: an exploratory study","volume":"14","author":"McIntyre","year":"2019","journal-title":"Diagn. Pathol."},{"issue":"22","key":"10.1016\/j.critrevonc.2022.103745_bib38","doi-asserted-by":"crossref","first-page":"31681","DOI":"10.18632\/oncotarget.9426","article-title":"The impact of the MYB-NFIB fusion proto-oncogene in vivo","volume":"7","author":"Mikse","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1158\/1078-0432.CCR-15-2867-T","article-title":"Novel MYBL1 gene rearrangements with recurrent MYBL1-NFIB fusions in salivary adenoid cystic carcinomas lacking t(6;9) translocations","volume":"22","author":"Mitani","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.critrevonc.2022.103745_bib40","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/1078-0432.CCR-11-1870","article-title":"Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome","volume":"17","author":"Mitani","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103745_bib41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0092-8674(91)90099-K","article-title":"A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis","volume":"65","author":"Mucenski","year":"1991","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103745_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gcc.2870100206","article-title":"Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands","volume":"10","author":"Nordkvist","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103745_bib43","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/PAS.0000000000000463","article-title":"Detection of MYB alterations and other immunohistochemical markers in primary cutaneous adenoid cystic carcinoma","volume":"39","author":"North","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10266-017-0326-1","article-title":"Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland","volume":"106","author":"Ono","year":"2018","journal-title":"Odontology"},{"key":"10.1016\/j.critrevonc.2022.103745_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.scr.2017.05.002","article-title":"MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma","volume":"21","author":"Panaccione","year":"2017","journal-title":"Stem Cell Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmg.2015.11.016","article-title":"Karyotype is not dead (yet)!","volume":"59","author":"Pasquier","year":"2016","journal-title":"Eur. J. Med. Genet."},{"issue":"44","key":"10.1016\/j.critrevonc.2022.103745_bib47","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck","volume":"106","author":"Persson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2022.103745_bib48","article-title":"First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: the MYPHISMO study protocol (NCT03287427)","volume":"16","author":"Pham","year":"2019","journal-title":"Conte Clin. Trials Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"21","key":"10.1016\/j.critrevonc.2022.103745_bib50","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1182\/blood-2011-01-333013","article-title":"Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants","volume":"117","author":"Quelen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2022.103745_bib51","doi-asserted-by":"crossref","unstructured":"Ramsay, R.G., Gonda, T.J. , 2008. MYB function in normal and cancer cells. Nat. Rev. Cancer. vol. 8(issue 7), pp. 523\u201334. \u3008http:\/\/dx.doi.org\/10.1038\/nrc2439\u3009. PMID: 18574464. \u2013 This manuscript provides a borad review on MYB function, including the history behind its discovery.","DOI":"10.1038\/nrc2439"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103745_bib52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1158\/1940-6207.CAPR-15-0316","article-title":"Whole-genome sequencing of salivary gland adenoid cystic carcinoma","volume":"9","author":"Rettig","year":"2016","journal-title":"Cancer Prev. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103745_bib53","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.molcel.2015.04.011","article-title":"BET bromodomain inhibition suppresses the function of hematopoietic transcription factors in acute myeloid leukemia","volume":"58","author":"Roe","year":"2015","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103745_bib54","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1097\/JTO.0000000000000656","article-title":"Histopathologic and cytogenetic features of pulmonary adenoid cystic carcinoma","volume":"10","author":"Roden","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103745_bib55","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/PAS.0000000000001616","article-title":"RNA in situ hybridization facilitates sensitive and specific diagnosis of adenoid cystic carcinoma regardless of translocation status","volume":"45","author":"Rooper","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103745_bib56","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1073\/pnas.77.5.3004","article-title":"Identification of a proviral genome associated with avian myeloblastic leukemia","volume":"77","author":"Souza","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib57","first-page":"773","article-title":"Establishment of patient-derived xenograft models of adenoid cystic carcinoma to assess pre-clinical efficacy of combination therapy of a PI3K inhibitor and retinoic acid","volume":"11","author":"Sun","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103745_bib58","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41379-018-0008-8","article-title":"and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts","volume":"31","author":"Togashi","year":"2018","journal-title":"Mod. Pathol."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103745_bib59","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.ophtha.2013.03.030","article-title":"Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics","volume":"120","author":"von Holstein","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/PAS.0b013e3182002777","article-title":"MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation","volume":"35","author":"West","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103745_bib61","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2007.07.021","article-title":"MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb","volume":"131","author":"Xiao","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PGP.0000000000000324","article-title":"Frequent NFIB-associated gene rearrangement in adenoid cystic carcinoma of the vulva","volume":"36","author":"Xing","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103745_bib63","first-page":"1579","article-title":"MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma","volume":"54","author":"Xu","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2022.103745_bib64","article-title":"Preliminary results of the efficacy and safety of all-trans retinoic acid combined with low-dose apatinib in the treatment of patients with recurrent\/metastatic adenoid cystic carcinoma of the head and neck","volume":"39","author":"Ye","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103745_bib65","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.canlet.2021.07.010","article-title":"Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner","volume":"520","author":"Yusenko","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2022.103745_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2020.01.039","article-title":"Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells","volume":"479","author":"Yusenko","year":"2020","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103745_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood-2008-01-136218","article-title":"The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells","volume":"113","author":"Zhao","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103745_bib68","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3892\/or.2013.2677","article-title":"Oncogenic chromosomal translocations and human cancer (review)","volume":"30","author":"Zheng","year":"2013","journal-title":"Oncol. Rep."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282200169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282200169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:43:10Z","timestamp":1760902990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282200169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":68,"alternative-id":["S104084282200169X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103745","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103745"}}